You just read:

New Phase 3 STELARA® (ustekinumab) Data Show Positive Results As Maintenance Therapy In Adults With Moderate To Severe Ulcerative Colitis

News provided by

Janssen Pharmaceutical Companies of Johnson & Johnson

Mar 11, 2019, 08:00 ET